"I've been absolutely blown away by the microRNA field and the way it's blossomed," University of Massachusetts Medical School researcher and Nobel laureate Craig Mello said. "There is just one story after another [showing that] microRNAs … are very critical to many aspects of either disease or development."
The company said it is working with the City of Hope to investigate the vector-based delivery of an anti-HIV RNA cocktail composed of pHIV7, an shRNA targeting an exon in HIV-1 tat/rev, and a Tar decoy.
Wisconsin's BioForward names Renk as executive director; Douglas to lead BioInnovation Institute; City of Hope promotes general counsel staffers; Greenberg Traurig's Dykeman joins MLSC task force; and Alta Partners promotes Alexander and Tomasi
This is the second vaccine-development partnership struck between Advaxis and City of Hope in as many years, further cementing an ongoing and mutually beneficial research partnership between the company and the cancer research center, according to an Advaxis executive.
Cenix BioScience, AstraZeneca, RXi Pharmaceuticals, Dicerna Pharmaceuticals, Intradigm, US Patent and Trademark Office, Integrated DNA Technologies, VH Bio, Asuragen, Agilent Technologies, Proceedings of the National Academy of Sciences